UiPath Inc. (NYSE:PATH - Get Free Report) CFO Ashim Gupta sold 47,227 shares of the stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $13.06, for a total transaction of $616,784.62. Following the completion of the transaction, the chief financial officer now directly owns 856,538 shares of the company's stock, valued at $11,186,386.28. This trade represents a 5.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
UiPath Price Performance
Shares of NYSE:PATH traded up $0.49 during mid-day trading on Monday, hitting $13.77. The company had a trading volume of 17,173,577 shares, compared to its average volume of 9,825,881. The firm has a fifty day moving average price of $13.50 and a 200 day moving average price of $12.74. The company has a market capitalization of $7.57 billion, a PE ratio of -86.06 and a beta of 0.96. UiPath Inc. has a one year low of $10.37 and a one year high of $27.87.
Institutional Trading of UiPath
Several hedge funds have recently modified their holdings of the stock. Cowa LLC increased its stake in shares of UiPath by 4.4% in the 3rd quarter. Cowa LLC now owns 26,681 shares of the company's stock valued at $342,000 after acquiring an additional 1,118 shares in the last quarter. Nations Financial Group Inc. IA ADV grew its position in UiPath by 6.8% in the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 26,090 shares of the company's stock valued at $334,000 after purchasing an additional 1,654 shares during the period. Amalgamated Bank grew its position in UiPath by 7.1% in the 3rd quarter. Amalgamated Bank now owns 27,312 shares of the company's stock valued at $350,000 after purchasing an additional 1,811 shares during the period. Thrivent Financial for Lutherans grew its position in UiPath by 10.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 20,881 shares of the company's stock valued at $267,000 after purchasing an additional 1,995 shares during the period. Finally, Future Financial Wealth Managment LLC acquired a new stake in UiPath in the 3rd quarter valued at $26,000. Institutional investors own 62.50% of the company's stock.
Analyst Ratings Changes
PATH has been the subject of several recent research reports. UBS Group initiated coverage on UiPath in a research note on Thursday, December 12th. They issued a "sell" rating and a $14.00 price objective for the company. BMO Capital Markets upped their price objective on UiPath from $15.00 to $16.00 and gave the company a "market perform" rating in a research note on Friday, December 6th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $16.00 price objective on shares of UiPath in a research note on Friday, December 6th. Morgan Stanley upped their price objective on UiPath from $15.00 to $16.00 and gave the company an "equal weight" rating in a research note on Friday, December 6th. Finally, Wells Fargo & Company lowered their price objective on UiPath from $15.00 to $13.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 23rd. One analyst has rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $17.50.
Read Our Latest Stock Analysis on PATH
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.